Skip to content

Discovery Technologies

Our expertise in biology, robotics, in silico analysis and bioinformatics helps cell and gene therapy pioneers advance the discovery phase of their clinical candidates.

CAR-T & Antibody Discovery

OXGENE’s proprietary CAR-T / antibody discovery platform targets challenging membrane proteins for the development of your CAR-T and other biologics.

CRISPR Libraries and Screening

Automated CRISPR screening, arrayed library production and cell line engineering services to accelerate target identification and validation.

AAV Capsid Discovery

We use proprietary technologies to identify and characterise novel AAV serotypes screened to your custom specification.

Promoter Discovery

We deploy proprietary technologies to uncover novel promoters to help maximise viral vector yield and transgene expression for your cell and gene therapies.

OXGENE provides an integrated solution that supports your entire discovery and validation workflow

Get in touch

Are you thinking ahead to clinical manufacture?


Our technologies help pioneering cell and gene therapy companies achieve high-titre, scalable and cost-effective viral vector production.

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.

Our single technology platform that fully connects our smart labs with our customer service proposition.


Connex revolutionises DNA design, optimization and assembly by ensuring the highest levels of quality control, efficiency and project management available for any client.

OXGENE has fully integrated all its smart labs and robotic production processes within a single technology platform that allows real-time project updates for our customers.